» Articles » PMID: 28253315

Introducing Malaria Rapid Diagnostic Tests in Private Medicine Retail Outlets: A Systematic Literature Review

Abstract

Background: Many patients with malaria-like symptoms seek treatment in private medicine retail outlets (PMR) that distribute malaria medicines but do not traditionally provide diagnostic services, potentially leading to overtreatment with antimalarial drugs. To achieve universal access to prompt parasite-based diagnosis, many malaria-endemic countries are considering scaling up malaria rapid diagnostic tests (RDTs) in these outlets, an intervention that may require legislative changes and major investments in supporting programs and infrastructures. This review identifies studies that introduced malaria RDTs in PMRs and examines study outcomes and success factors to inform scale up decisions.

Methods: Published and unpublished studies that introduced malaria RDTs in PMRs were systematically identified and reviewed. Literature published before November 2016 was searched in six electronic databases, and unpublished studies were identified through personal contacts and stakeholder meetings. Outcomes were extracted from publications or provided by principal investigators.

Results: Six published and six unpublished studies were found. Most studies took place in sub-Saharan Africa and were small-scale pilots of RDT introduction in drug shops or pharmacies. None of the studies assessed large-scale implementation in PMRs. RDT uptake varied widely from 8%-100%. Provision of artemisinin-based combination therapy (ACT) for patients testing positive ranged from 30%-99%, and was more than 85% in five studies. Of those testing negative, provision of antimalarials varied from 2%-83% and was less than 20% in eight studies. Longer provider training, lower RDT retail prices and frequent supervision appeared to have a positive effect on RDT uptake and provider adherence to test results. Performance of RDTs by PMR vendors was generally good, but disposal of medical waste and referral of patients to public facilities were common challenges.

Conclusions: Expanding services of PMRs to include malaria diagnostic services may hold great promise to improve malaria case management and curb overtreatment with antimalarials. However, doing so will require careful planning, investment and additional research to develop and sustain effective training, supervision, waste-management, referral and surveillance programs beyond the public sector.

Citing Articles

Truth is relative; Client report versus provider report, a post-modern analysis of data from a trial in the private retail medicine sector.

Chepkwony T, Amunga M, Kimachas E, Kipkoech J, Robie E, Wekesa A Res Sq. 2024; .

PMID: 39502782 PMC: 11537346. DOI: 10.21203/rs.3.rs-5005686/v1.


Bangladesh should engage the private sector for malaria elimination by 2030.

McArdle R, Phru C, Hossain M, Alam M, Haldar K Lancet Reg Health Southeast Asia. 2024; 31:100487.

PMID: 39399862 PMC: 11465204. DOI: 10.1016/j.lansea.2024.100487.


Improving malaria case management with artemisinin-based combination therapies and malaria rapid diagnostic tests in private medicine retail outlets in sub-Saharan Africa: A systematic review.

Goodman C, Tougher S, Shang T, Visser T PLoS One. 2024; 19(7):e0286718.

PMID: 39074113 PMC: 11285950. DOI: 10.1371/journal.pone.0286718.


A cluster-randomized trial of client and provider directed financial interventions to align incentives with appropriate case management in private medicine retailers: Results of the TESTsmART trial in Lagos, Nigeria.

Visser T, Laktabai J, Kimachas E, Kipkoech J, Menya D, Arthur D PLOS Glob Public Health. 2024; 4(7):e0002938.

PMID: 38954701 PMC: 11218985. DOI: 10.1371/journal.pgph.0002938.


A Study of Childhood Malaria trends at the University of Port Harcourt Teaching Hospital: 2006 - 2018.

Yarhere I, Nte A Niger Med J. 2024; 64(2):272-280.

PMID: 38898967 PMC: 11185816.


References
1.
Altaras R, Nuwa A, Agaba B, Streat E, Tibenderana J, Strachan C . Why do health workers give anti-malarials to patients with negative rapid test results? A qualitative study at rural health facilities in western Uganda. Malar J. 2016; 15:23. PMC: 4709931. DOI: 10.1186/s12936-015-1020-9. View

2.
Chandler C, Jones C, Boniface G, Juma K, Reyburn H, Whitty C . Guidelines and mindlines: why do clinical staff over-diagnose malaria in Tanzania? A qualitative study. Malar J. 2008; 7:53. PMC: 2323020. DOI: 10.1186/1475-2875-7-53. View

3.
Thiam S, Thior M, Faye B, Ndiop M, Diouf M, Diouf M . Major reduction in anti-malarial drug consumption in Senegal after nation-wide introduction of malaria rapid diagnostic tests. PLoS One. 2011; 6(4):e18419. PMC: 3071817. DOI: 10.1371/journal.pone.0018419. View

4.
Awor P, Wamani H, Tylleskar T, Peterson S . Drug seller adherence to clinical protocols with integrated management of malaria, pneumonia and diarrhoea at drug shops in Uganda. Malar J. 2015; 14:277. PMC: 4502601. DOI: 10.1186/s12936-015-0798-9. View

5.
Tougher S, Ye Y, Amuasi J, Kourgueni I, Thomson R, Goodman C . Effect of the Affordable Medicines Facility--malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data. Lancet. 2012; 380(9857):1916-26. DOI: 10.1016/S0140-6736(12)61732-2. View